Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China | |
Wei, Lai; Xu, Xiaoyun; Guan, Yujuan; Zheng, Sujun; Sheng, Jifang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng | |
2018 | |
卷号 | 68 |
会议录 | HEPATOLOGY |
语种 | 英语 |
URL标识 | 查看原文 |
ISSN号 | 0270-9139 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3600952 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wei, Lai,Xu, Xiaoyun,Guan, Yujuan,et al. Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论